BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 29027212)

  • 1. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.
    Macdougall IC; Comin-Colet J; Breymann C; Spahn DR; Koutroubakis IE
    Adv Ther; 2020 May; 37(5):1960-2002. PubMed ID: 32297281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
    Wu M; Sun D; Tyner K; Jiang W; Rouse R
    Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
    Pollock RF; Muduma G
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1439-1446. PubMed ID: 29032713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
    Schnorr J; Fütterer S; Spicher K; Catarinolo M; Schlösser C; Enzmann H; Langguth P
    Regul Toxicol Pharmacol; 2018 Apr; 94():293-298. PubMed ID: 29454888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron nanoparticles as food additives and food supplements, regulatory and legislative perspectives.
    Chavarría-Fernández SM; Jiménez-Alvarado R; Santos-López EM; Hernández-Hernandez AA; Cariño-Cortés R
    Food Sci Biotechnol; 2024 May; 33(6):1295-1305. PubMed ID: 38585565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
    Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
    Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of nanoparticles and routes of administration.
    Chenthamara D; Subramaniam S; Ramakrishnan SG; Krishnaswamy S; Essa MM; Lin FH; Qoronfleh MW
    Biomater Res; 2019; 23():20. PubMed ID: 31832232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Irons: From Basic Science to Clinical Practice.
    Bhandari S; Pereira DIA; Chappell HF; Drakesmith H
    Pharmaceuticals (Basel); 2018 Aug; 11(3):. PubMed ID: 30150598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.
    Stefanova D; Raychev A; Deville J; Humphries R; Campeau S; Ruchala P; Nemeth E; Ganz T; Bulut Y
    Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron sucrose: assessing the similarity between the originator drug and its intended copies.
    Di Francesco T; Philipp E; Borchard G
    Ann N Y Acad Sci; 2017 Nov; 1407(1):63-74. PubMed ID: 29168243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute injury with intravenous iron and concerns regarding long-term safety.
    Bishu K; Agarwal R
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Iron Deficiency Anemia in Heart Failure.
    Saraon T; Katz SD
    Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Stein J; Dignass A; Chow KU
    Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose.
    Elford P; Bouchard J; Jaillet L; Pearson N; Rogue A; Sabadie C; Forster R
    J Pharmacol Toxicol Methods; 2013; 68(3):374-83. PubMed ID: 23624021
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.